HeartSciences (HSCS) Competitors $3.98 -0.37 (-8.51%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$4.10 +0.12 (+3.04%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. PSTV, NXL, IRIX, MHUA, LYRA, INBS, WOK, DHAI, SSKN, and PAVMShould you be buying HeartSciences stock or one of its competitors? The main competitors of HeartSciences include Plus Therapeutics (PSTV), Nexalin Technology (NXL), IRIDEX (IRIX), Meihua International Medical Technologies (MHUA), Lyra Therapeutics (LYRA), Intelligent Bio Solutions (INBS), WORK Medical Technology Group (WOK), DIH Holding US (DHAI), Strata Skin Sciences (SSKN), and PAVmed (PAVM). These companies are all part of the "medical equipment" industry. HeartSciences vs. Its Competitors Plus Therapeutics Nexalin Technology IRIDEX Meihua International Medical Technologies Lyra Therapeutics Intelligent Bio Solutions WORK Medical Technology Group DIH Holding US Strata Skin Sciences PAVmed Plus Therapeutics (NASDAQ:PSTV) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Which has stronger earnings & valuation, PSTV or HSCS? HeartSciences has higher revenue and earnings than Plus Therapeutics. HeartSciences is trading at a lower price-to-earnings ratio than Plus Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPlus TherapeuticsN/AN/A-$12.98M-$2.94-0.11HeartSciences$20K214.92-$6.61M-$7.48-0.53 Which has more volatility & risk, PSTV or HSCS? Plus Therapeutics has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, HeartSciences has a beta of 2.57, meaning that its stock price is 157% more volatile than the S&P 500. Do analysts prefer PSTV or HSCS? Plus Therapeutics presently has a consensus target price of $10.83, suggesting a potential upside of 3,317.46%. HeartSciences has a consensus target price of $13.00, suggesting a potential upside of 226.63%. Given Plus Therapeutics' higher probable upside, research analysts plainly believe Plus Therapeutics is more favorable than HeartSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Plus Therapeutics 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50HeartSciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in PSTV or HSCS? 3.3% of Plus Therapeutics shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 5.5% of Plus Therapeutics shares are owned by company insiders. Comparatively, 1.8% of HeartSciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is PSTV or HSCS more profitable? HeartSciences has a net margin of 0.00% compared to Plus Therapeutics' net margin of -520.90%. Plus Therapeutics' return on equity of 0.00% beat HeartSciences' return on equity.Company Net Margins Return on Equity Return on Assets Plus Therapeutics-520.90% N/A -202.73% HeartSciences N/A -178.80%-109.28% Does the media favor PSTV or HSCS? In the previous week, Plus Therapeutics had 1 more articles in the media than HeartSciences. MarketBeat recorded 3 mentions for Plus Therapeutics and 2 mentions for HeartSciences. HeartSciences' average media sentiment score of 0.94 beat Plus Therapeutics' score of 0.00 indicating that HeartSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Plus Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHeartSciences beats Plus Therapeutics on 8 of the 14 factors compared between the two stocks. Get HeartSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeartSciencesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.70M$2.00B$5.61B$9.29BDividend YieldN/AN/A4.23%4.03%P/E Ratio-0.5334.2528.5419.58Price / Sales214.9215.04429.2495.01Price / CashN/A54.7436.0257.93Price / Book0.368.258.145.54Net Income-$6.61M-$62.39M$3.24B$257.73M7 Day Performance-8.92%-2.22%0.18%-0.08%1 Month Performance3.11%9.89%5.96%8.09%1 Year Performance-1.24%3.14%26.24%13.02% HeartSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeartSciences2.3552 of 5 stars$3.98-8.5%$13.00+226.6%-1.2%$4.70M$20K-0.5310Gap DownPSTVPlus Therapeutics1.6088 of 5 stars$0.33+10.9%$10.83+3,151.3%-82.7%$16.99M$5.82M-0.1120High Trading VolumeNXLNexalin Technology2.9879 of 5 stars$0.96+1.3%$5.00+419.8%-28.7%$16.53M$131.07K-1.163IRIXIRIDEX1.0719 of 5 stars$0.96+1.1%N/A-52.8%$16.12M$48.80M-2.23120Positive NewsMHUAMeihua International Medical Technologies1.3191 of 5 stars$0.41-1.2%N/A-51.9%$13.07M$96.91M0.00620Positive NewsGap UpLYRALyra Therapeutics2.6704 of 5 stars$9.25+2.4%$100.00+981.1%-44.4%$12.30M$1.53M-0.1550News CoverageAnalyst DowngradeINBSIntelligent Bio Solutions0.8873 of 5 stars$1.71+0.6%N/A-1.6%$11.82M$2.94M0.0010News CoveragePositive NewsGap UpWOKWORK Medical Technology GroupN/A$0.78+9.8%N/AN/A$11.38M$11.51M0.00226Positive NewsDHAIDIH Holding US0.6694 of 5 stars$0.23-4.9%N/A-92.3%$11.08M$64.47M-0.78N/ANews CoverageSSKNStrata Skin Sciences3.3131 of 5 stars$2.36-0.8%$6.00+154.2%-24.8%$9.84M$33.62M-1.04120High Trading VolumePAVMPAVmed4.3811 of 5 stars$0.55-6.1%$19.00+3,327.7%-39.0%$9.47M$2.99M0.7890Positive News Related Companies and Tools Related Companies Plus Therapeutics Competitors Nexalin Technology Competitors IRIDEX Competitors Meihua International Medical Technologies Competitors Lyra Therapeutics Competitors Intelligent Bio Solutions Competitors WORK Medical Technology Group Competitors DIH Holding US Competitors Strata Skin Sciences Competitors PAVmed Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartSciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSCS Stock Alerts